ClinicalTrials.govpublic full text
Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment
hepatocellular carcinoma, hcc, liver cancer, live cell carcinoma, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871534
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.